Furthermore, MRX-2843 enabled enhanced accumulation of dying tumor cells, ensuring adequate release of tumor-derived cGAMP and DAMPs to induce a strong STING-mediated secretion of type I interferon in TAMs and to improve immunogenicity. This evidence concerns the gene STING1 and neoplasm.